Metabolic Disease Clinical Trial
Official title:
Validation of a Healthy Metabolic Behavior Tool for Overweight and Obese Women
Verified date | November 2021 |
Source | KK Women's and Children's Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aims to validate and pilot test the short-term intervention effect of a newly developed healthy metabolic behaviour tool, named as the 6P tool, on dietary attitude/ practice and body weight changes over one month among overweight and obese women. A total of 50 women, aged 21-40 years, BMI ≥25 kg/m2, who are attending the preconception clinic and planning for a pregnancy over the next one year, will be invited to participate in this pilot study. The recruitment period is estimated to take up to 10 weeks, with subsequent 1 month follow-up visit.
Status | Completed |
Enrollment | 50 |
Est. completion date | September 30, 2021 |
Est. primary completion date | September 30, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 21 Years to 40 Years |
Eligibility | Inclusion Criteria: - age 21-40 years - body mass index >= 25 kg/m2 |
Country | Name | City | State |
---|---|---|---|
Singapore | KK Women's and Children's Hospital | Singapore |
Lead Sponsor | Collaborator |
---|---|
KK Women's and Children's Hospital |
Singapore,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Clarify, usefulness and acceptability of the 6P tool | Assessed by the feedback evaluation questionnaire | Follow up visit at 1 month | |
Other | Usefulness and acceptability for the nudges | Assessed by the nudges rating scale and feedback evaluation questionnaire | 1 month | |
Other | Other lifestyle changes | Assessed by the general lifestyle questionnaire | Between baseline and follow-up visit (1 month) | |
Primary | Meal portion size | Assessed by the portion size rating (scores1-7) in the 6P tool before and after the intervention. Higher score indicates higher portion size. | Between baseline and follow-up visit (1 month) | |
Primary | Vegetable intake | Assessed by the proportion assessment for vegetable intake in the 6P tool before and after the intervention | Between baseline and follow-up visit (1 month) | |
Primary | Pleasure food intake | Assessed by the frequency of pleasure food intake in the 6P tool before and after the intervention | Between baseline and follow-up visit (1 month) | |
Primary | Meal timing | Assessed by the percentage of total caloric intake during the day and night in the 6P tool before and after the intervention | Between baseline and follow-up visit (1 month) | |
Primary | Physical activity | Assessed by the duration of physical activity in the 6P tool before and after the intervention | Between baseline and follow-up visit (1 month) | |
Primary | Motivational level | Assessed by the rating of motivational level (scores 1-9) in the 6P tool before and after the intervention. Higher score indicates higher motivational level. | Between baseline and follow-up visit (1 month) | |
Secondary | Body weight changes | Weight changes in kg before and after the intervention | Between baseline and follow-up visit (1 month) | |
Secondary | Body mass index changes | Body mass index changes in kg/m2 before and after the intervention | Between baseline and follow-up visit (1 month) | |
Secondary | Dietary behavioral changes | Assessed by the Three Factor Eating Questionnaire before and after the intervention | Between baseline and follow-up visit (1 month) | |
Secondary | Activity intensity changes | Assessed by the International Physical activity Questionnaire | Between baseline and follow-up visit (1 month) | |
Secondary | Screen viewing time changes | Assessed by the Sedentary Behavioural Questionnaire | Between baseline and follow-up visit (1 month) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06188728 -
Husk Fiber Intervention on Metabolic Health of Centrally Obese School Teachers
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05081037 -
Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS)
|
N/A | |
Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|
||
Not yet recruiting |
NCT05461144 -
AI Models for Non-invasive Glycaemic Event Detection Using ECG in Type 1 Diabetics
|
||
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A | |
Active, not recruiting |
NCT05505994 -
The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin
|
Phase 3 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Completed |
NCT03675360 -
Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial
|
N/A | |
Recruiting |
NCT05711758 -
Efficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure
|
||
Recruiting |
NCT05112029 -
Metabolic Profile and Adipokine Levels in Young Hyperandrogenemic Females
|
||
Recruiting |
NCT03682640 -
Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes
|
Phase 2 | |
Completed |
NCT04854603 -
Dairy Products With Reduced Sugar and Blood Glucose
|
N/A | |
Recruiting |
NCT06024291 -
Reducing Circulating Sphingolipid Levels to Optimise Cardiometabolic Health - The SphingoFIT Trial
|
N/A | |
Recruiting |
NCT04904601 -
Freeze-dried Kale to Reduce Metabolic Risk in Saudi Subjects
|
N/A | |
Recruiting |
NCT04109586 -
Diet and Fat Mass After Traumatic Spinal Cord Injury
|
N/A | |
Recruiting |
NCT06009653 -
Effect of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity
|
Phase 4 | |
Completed |
NCT03067012 -
Nutritional Safety and Metabolic Benefits of Oncometabolic Surgery for Obese Gastric Cancer Patients
|
N/A | |
Recruiting |
NCT03309423 -
Is Venous to Arterial Conversion (v-TAC) of Blood Gas Reliable in Critical Ill Patients in the ICU?
|
N/A |